Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02218853 · ClinicalTrials.gov registry record
Psychosis and Affective Research Domains and Intermediate Phenotypes
A clinical trial of Bipolar I Disorder, Unspecified, With Psychotic Features and Bipolar I Disorder, Unspecified, Without Psychotic Features, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 113
- Enrollment target
- 1
- Study location
NCT02218853: Completed study of Bipolar I Disorder, Unspecified, With Psychotic Features and Bipolar I Disorder, Unspecified, Without Psychotic Features, sponsored by University of Texas Southwestern Medical Center.
NCT02218853 is a study of Bipolar I Disorder, Unspecified, With Psychotic Features and Bipolar I Disorder, Unspecified, Without Psychotic Features that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 113 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02218853, a study of Bipolar I Disorder, Unspecified, With Psychotic Features and Bipolar I Disorder, Unspecified, Without Psychotic Features, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 113 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this multi-site research collaboration is to test the manifestation and distribution of biological markers for psychosis and affect dimensions across the schizophrenia/bipolar (SZ-BD) diagnostic boundary, and to examine heritability and genetic associations for these biological markers.
Conditions Studied
Study Locations (1)
Texas
- UT Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2014-04 |
| Est. Completion | 2017-12 |
What the finished NCT02218853 record still lists
NCT02218853 is an observational study that tracks outcomes without assigning an intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Bipolar I Disorder, Unspecified, With Psychotic Features appearing as the primary indexed condition, and to 0 interventions.
NCT02218853 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02218853 about?
NCT02218853 is a clinical study titled "Psychosis and Affective Research Domains and Intermediate Phenotypes". The objective of this multi-site research collaboration is to test the manifestation and distribution of biological markers for psychosis and affect dimensions across the schizophrenia/bipolar (SZ-BD) diagnostic boundary, and to examine heritability and genetic associations for these biological mark...
What is the current status of trial NCT02218853?
This trial is currently completed. The enrollment target is 113 participants. The study started on 2014-04. Estimated completion is 2017-12.
What conditions does trial NCT02218853 study?
This clinical trial studies the following conditions: Bipolar I Disorder, Unspecified, With Psychotic Features, Bipolar I Disorder, Unspecified, Without Psychotic Features.
Who is sponsoring clinical trial NCT02218853?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02218853 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00748254 · 113 participants
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
- NCT04753190 · 113 participants · NA
Light Timing Study
- NCT05799248 · 113 participants · Phase 3
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
- NCT07216105 · 113 participants · Phase 1
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia